1
|
Pérez Lázaro C, López-Bravo A, Gómez-Escalonilla Escobar C, Aguirre C, de Felipe A, de la Riva P, Calleja S, Arjona A, Serrano Ponz M, Navarro-Pérez MP, Delgado-Mederos R, Bashir Viturro S, Llul L, Egido J, García Madrona S, Díez González N, Benavente-Fernández L, de la Torre-Colmenero JD, Tejada Meza H, Vesperinas-Castro A, Sánchez-Cirera L, Trillo S. Management of cerebral venous thrombosis in Spain: MOTIVATE descriptive study. Neurologia 2024; 39:226-234. [PMID: 37442428 DOI: 10.1016/j.nrleng.2023.07.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2021] [Accepted: 05/22/2021] [Indexed: 07/15/2023] Open
Abstract
INTRODUCTION Cerebral venous thrombosis (CVT) is an uncommon cause of stroke that mainly affects young adults. Early, accurate diagnosis can reduce the rate and severity of complications. OBJECTIVE The aim of this study was to analyse the clinical characteristics, management, and treatment of CVT in different centres in Spain. METHODS We conducted a multicentre, retrospective, descriptive study of patients hospitalised due to CVT between 2008 and 2017 at 10 Spanish centres. RESULTS We included 256 patients, with a mean age (SD) of 49.8 (18.7) years; 51% of patients were women. The most frequent symptoms were headache (73%), focal deficits (50%), epileptic seizures (33%), and encephalopathy (21%). The most frequent localisations were the superior sagittal sinus (12.5%), the transverse sinus (10.9%), and 2 or more sinuses or veins (66.4%). Thrombophilia was the most frequent known aetiology (24%), and was most commonly associated with the prothrombin G20210A mutation (19%). Forty-six percent of patients were treated with antithrombotics for 3 to 6 months, 21% for one year, and 22.6% required indefinite anticoagulation. Endovascular therapy was performed in 5% of cases, and 33% required neurosurgery. Regarding outcomes, 75% of patients were independent at 3 months (modified Rankin Scale [mRS] score ≤ 2), with papilloedema (P = .03), focal deficits (P = .001), and encephalopathy (P < .001) showing a statistically significant association with poor prognosis (mRS > 3). The in-hospital mortality rate was 4.3%, with a 3-month mortality rate of 6.3%. CONCLUSION The diverse risk factors and variable presentation of CVT represent a challenge in the diagnosis and treatment of this condition. To improve prognosis and reduce mortality, it is essential to establish management protocols for this entity.
Collapse
Affiliation(s)
- C Pérez Lázaro
- Hospital Clínico Universitario «Lozano Blesa», Instituto de Investigación Sanitaria Aragón (IIS-A), Zaragoza, Spain
| | - A López-Bravo
- Hospital Clínico Universitario «Lozano Blesa», Instituto de Investigación Sanitaria Aragón (IIS-A), Zaragoza, Spain.
| | | | | | | | - P de la Riva
- Hospital Universitario Donosti, San Sebastián, Spain
| | - S Calleja
- Hospital Universitario Central de Asturias, Oviedo, Spain
| | - A Arjona
- Hospital Universitario Torrecárdenas, Almería, Spain
| | | | - M P Navarro-Pérez
- Hospital Clínico Universitario «Lozano Blesa», Instituto de Investigación Sanitaria Aragón (IIS-A), Zaragoza, Spain
| | | | | | - L Llul
- Hospital Clínic, Barcelona, Spain
| | - J Egido
- Hospital Clínico San Carlos, Madrid, Spain
| | | | | | | | | | - H Tejada Meza
- Hospital Universitario Miguel Servet, Zaragoza, Spain
| | | | | | - S Trillo
- Hospital La Princesa, Madrid, Spain
| |
Collapse
|
2
|
Campo-Caballero D, de la Riva P, de Arce A, Martínez-Zabaleta M, Rodríguez-Antigüedad J, Ekiza J, Iruzubieta P, Purroy F, Fuentes B, de Lera Alfonso M, Krupinski J, Mengual Chirife JJ, Palomeras E, Guisado-Alonso D, Rodríguez-Yáñez M, Ustrell X, Tejada García J, de Felipe Mimbrera A, Paré-Curell M, Tembl J, Cajaraville S, Garcés M, Serena J. Reperfusion therapy in acute ischaemic stroke due to cervical and cerebral artery dissection: Results from a Spanish multicentre study. Neurologia (Engl Ed) 2022:S2173-5808(22)00074-8. [PMID: 35842129 DOI: 10.1016/j.nrleng.2020.10.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2020] [Accepted: 10/05/2020] [Indexed: 11/17/2022] Open
Abstract
INTRODUCTION Ischaemic stroke (IS) due to cervical and cerebral artery dissection (CAD) is a rare entity, and few data are available on the use of such reperfusion therapies as intravenous fibrinolysis and mechanical thrombectomy in these patients. We analysed the use of these treatments in patients with IS due to CAD and compared them against patients receiving reperfusion treatment for IS of other aetiologies. METHODS We conducted an observational, retrospective, multicentre study of patients with IS due to CAD recorded in the National Stroke Registry of the Spanish Society of Neurology during the period 2011-2019. Comparative analyses were performed between: a) patients with CAD treated and not treated with reperfusion therapies and b) patients treated with reperfusion for IS due to CAD and patients treated with reperfusion for IS due to other causes. Epidemiological data, stroke variables, and outcomes at discharge and at 3 months were included in the analysis. RESULTS The study included 21,037 patients with IS: 223 (1%) had IS due to CAD, of whom 68 (30%) received reperfusion treatment. Reperfusion treatments were used less frequently in cases of vertebral artery dissection and more frequently in patients with carotid artery occlusion. Compared to patients with IS due to other causes, patients with CAD were younger, more frequently underwent mechanical thrombectomy, and less frequently received intravenous fibrinolysis. Rates of haemorrhagic complications, mortality, and independence at 3 months were similar in both groups. CONCLUSIONS Reperfusion therapy is frequently used in patients with IS due to CAD. The outcomes of these patients demonstrate the efficacy and safety of reperfusion treatments, and are comparable to the outcomes of patients with IS due to other aetiologies.
Collapse
Affiliation(s)
- D Campo-Caballero
- Servicio de Neurología, Hospital Universitario Donostia, Sant Sebastián, Spain.
| | - P de la Riva
- Servicio de Neurología, Hospital Universitario Donostia, Sant Sebastián, Spain
| | - A de Arce
- Servicio de Neurología, Hospital Universitario Donostia, Sant Sebastián, Spain
| | - M Martínez-Zabaleta
- Servicio de Neurología, Hospital Universitario Donostia, Sant Sebastián, Spain
| | | | - J Ekiza
- Servicio de Neurología, Hospital Universitario Donostia, Sant Sebastián, Spain
| | - P Iruzubieta
- Servicio de Neurología, Hospital Universitario Donostia, Sant Sebastián, Spain
| | - F Purroy
- Servicio de Neurología, Hospital Arnau de Vilanova de Lleida, Lleida, Spain
| | - B Fuentes
- Servicio de Neurología, Hospital Universitario La Paz, Madrid, Spain
| | - M de Lera Alfonso
- Servicio de Neurología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
| | - J Krupinski
- Servicio de Neurología, Hospital Universitari Mútua de Terrassa, Terrassa, Spain
| | | | - E Palomeras
- Servicio de Neurología, Hospital de Mataró, Mataró, Spain
| | - D Guisado-Alonso
- Servicio de Neurología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | - M Rodríguez-Yáñez
- Servicio de Neurología, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
| | - X Ustrell
- Servicio de Neurología, Hospital Universitari Joan XXIII, Tarragona, Spain
| | | | | | - M Paré-Curell
- Servicio de Neurología, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
| | - J Tembl
- Servicio de Neurología, Hospital Universitari i Politécnic La Fe, Valencia, Spain
| | - S Cajaraville
- Servicio de Neurología, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain
| | - M Garcés
- Servicio de Neurología, Hospital Clínico Lozano Blesa, Zaragoza, Spain
| | - J Serena
- Servicio de Neurología, Hospital Universitari Dr. Josep Trueta, Girona, Spain
| |
Collapse
|
3
|
Fernández-Eulate G, Arocena P, Muñoz-Lopetegi A, Rodriguez-Antigüedad J, Campo-Caballero D, Equiza J, Andrés N, de Arce A, Gonzalez F, Diez N, Basterrechea J, Suquia E, de la Riva P, Martinez-Zabaleta M. Attention to acute cerebrovascular disease in Guipúzcoa: Description of the results of a reference hospital in a centralized care model. Neurologia 2022; 37:355-361. [PMID: 31053483 DOI: 10.1016/j.nrl.2019.03.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2018] [Revised: 02/22/2019] [Accepted: 03/03/2019] [Indexed: 11/21/2022] Open
Abstract
INTRODUCTION In the last 15 years, considerable improvements have been made in acute stroke care in Guipuzkoa, including the implementation of a centralised care model at Hospital Universitario Donostia (HUD), improved coordination between professionals, early detection campaigns, new treatments, a stroke unit, and specific rehabilitation. The aim of this work is to describe the results of a reference hospital (HUD) in a centralised care model. MATERIAL AND METHODS We performed a retrospective observational study of a sample of patients discharged between August and December 2015 from the HUD with a diagnosis of acute stroke (ICD-9-CM codes 430-436, except 433.10). We review patients' baseline characteristics, acute-phase care, and functional outcomes and mortality at discharge and at one year. RESULTS AND DISCUSSION We identified 536 patients, with a mean age of 73.6 years and a high comorbidity rate. Ischaemic stroke accounted for 64.8% of patients, followed by haemorrhagic stroke (20%) and transient ischaemic attack (14.8%). A total of 53% of patients were attended in <6 hours, with code stroke being activated in 37.1%; 52.2% of patients were admitted to the stroke unit. Intravenous therapy was administered to 8.3% of patients with ischaemic stroke, and 9.5% underwent mechanical thrombectomy. Surgery was performed in 12.1% patients with haemorrhagic stroke. Rehabilitation was started at hospital in 56% of patients, and 39.6% continued with this treatment at discharge. Mortality was 13.8% at discharge and 25.9% at one year (ischaemic stroke, 25.3%; haemorrhagic stroke, 47.5%); these figures are lower than those previously reported in Guipuzkoa. At one year, 62.5% of patients had a Barthel Index score of 95-100, and 50% a modified Rankin Scale score of 0-2. CONCLUSIONS After the strategic changes implemented in acute stroke care in Guipuzkoa, including the centralisation of the acute stroke care model, mortality rates at discharge and at one year are lower in 2015 than the previously reported rates, with similar rates of independence. These results are consistent with those published by other Spanish and European centres.
Collapse
Affiliation(s)
- G Fernández-Eulate
- Servicio de Neurología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España.
| | - P Arocena
- Facultad de Medicina, UPV, San Sebastián, Guipúzcoa, España
| | - A Muñoz-Lopetegi
- Servicio de Neurología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España
| | - J Rodriguez-Antigüedad
- Servicio de Neurología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España
| | - D Campo-Caballero
- Servicio de Neurología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España
| | - J Equiza
- Servicio de Neurología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España
| | - N Andrés
- Servicio de Neurología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España
| | - A de Arce
- Servicio de Neurología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España
| | - F Gonzalez
- Servicio de Neurología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España
| | - N Diez
- Servicio de Neurología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España
| | - J Basterrechea
- Servicio de Calidad, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España
| | - E Suquia
- Servicio de Calidad, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España
| | - P de la Riva
- Servicio de Neurología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España
| | - M Martinez-Zabaleta
- Servicio de Neurología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España; Facultad de Medicina, UPV, San Sebastián, Guipúzcoa, España
| |
Collapse
|
4
|
Pérez Lázaro C, López-Bravo A, Gómez-Escalonilla Escobar C, Aguirre C, de Felipe A, de la Riva P, Calleja S, Arjona A, Serrano Ponz M, Navarro-Pérez MP, Delgado-Mederos R, Bashir Viturro S, Llul L, Egido J, García Madrona S, Díez González N, Benavente Fernández L, de la Torre Colmenero JD, Tejada Meza H, Vesperinas Castro A, Sánchez Cirera L, Trillo S. Management of cerebral venous thrombosis in Spain: MOTIVATE descriptive study. Neurologia 2021:S0213-4853(21)00116-X. [PMID: 34511275 DOI: 10.1016/j.nrl.2021.05.016] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2021] [Revised: 04/29/2021] [Accepted: 05/22/2021] [Indexed: 11/23/2022] Open
Abstract
INTRODUCTION Cerebral venous thrombosis (CVT) is an uncommon cause of stroke that mainly affects young adults. Early, accurate diagnosis can reduce the rate and severity of complications. OBJECTIVE The aim of this study was to analyse the clinical characteristics, management, and treatment of CVT in different centres in Spain. METHODS We conducted a multicentre, retrospective, descriptive study of patients hospitalised due to CVT between 2008 and 2017 at 11 Spanish centres. RESULTS We included 256 patients, with a mean age (SD) of 49.8 (18.7) years; 51% of patients were women. The most frequent symptoms were headache (73%), focal deficits (50%), epileptic seizures (33%), and encephalopathy (21%). The most frequent localisations were the superior sagittal sinus (12.5%), the transverse sinus (10.9%), and 2 or more sinuses or veins (66.4%). Thrombophilia was the most frequent known aetiology (24%), and was most commonly associated with the prothrombin G20210A mutation (19%). Forty-six percent of patients were treated with antithrombotics for 3-6 months, 21% for one year, and 22.6% required indefinite anticoagulation. Endovascular therapy was performed in 5% of cases, and 33% required neurosurgery. Regarding outcomes, 75% of patients were independent at 3 months (modified Rankin Scale [mRS] score ≤ 2), with papilloedema (P=.03), focal deficits (P=.001), and encephalopathy (P <.001) showing a statistically significant association with poor prognosis (mRS> 3). The in-hospital mortality rate was 4.3%, with a 3-month mortality rate of 6.3%. CONCLUSION The diverse risk factors and variable presentation of CVT represent a challenge in the diagnosis and treatment of this condition. To improve prognosis and reduce mortality, it is essential to establish management protocols for this entity.
Collapse
Affiliation(s)
- C Pérez Lázaro
- Hospital Clínico Universitario «Lozano Blesa», Instituto de Investigación Sanitaria Aragón (IIS-A), Zaragoza, España
| | - A López-Bravo
- Hospital Clínico Universitario «Lozano Blesa», Instituto de Investigación Sanitaria Aragón (IIS-A), Zaragoza, España.
| | | | - C Aguirre
- Hospital La Princesa, Madrid, España
| | | | - P de la Riva
- Hospital Universitario Donosti, San Sebastián, España
| | - S Calleja
- Hospital Universitario Central de Asturias, Oviedo, España
| | - A Arjona
- Hospital Universitario Torrecárdenas, Almería, España
| | | | - M P Navarro-Pérez
- Hospital Clínico Universitario «Lozano Blesa», Instituto de Investigación Sanitaria Aragón (IIS-A), Zaragoza, España
| | | | | | - L Llul
- Hospital Clínic, Barcelona, España
| | - J Egido
- Hospital Clínico San Carlos, Madrid, España
| | | | | | | | | | - H Tejada Meza
- Hospital Universitario Miguel Servet, Zaragoza, España
| | | | | | - S Trillo
- Hospital La Princesa, Madrid, España
| |
Collapse
|
5
|
Campo-Caballero D, de la Riva P, de Arce A, Martínez-Zabaleta M, Rodríguez-Antigüedad J, Ekiza J, Iruzubieta P, Purroy F, Fuentes B, de Lera Alfonso M, Krupinski J, Mengual Chirife JJ, Palomeras E, Guisado-Alonso D, Rodríguez-Yáñez M, Ustrell X, Tejada García J, de Felipe Mimbrera A, Paré-Curell M, Tembl J, Cajaraville S, Garcés M, Serena J. Reperfusion treatment in acute ischaemic stroke due to cervical and cerebral artery dissection: results of a Spanish national multicentre study. Neurologia 2020; 38:S0213-4853(20)30430-8. [PMID: 33358059 DOI: 10.1016/j.nrl.2020.10.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2020] [Revised: 09/14/2020] [Accepted: 10/05/2020] [Indexed: 10/22/2022] Open
Abstract
INTRODUCTION Ischaemic stroke (IS) due to cervical and cerebral artery dissection (CAD) is a rare entity, and few data are available on the use of such reperfusion therapies as intravenous fibrinolysis and mechanical thrombectomy in these patients. We analysed the use of these treatments in patients with IS due to CAD and compared them against patients receiving reperfusion treatment for IS of other aetiologies. METHOD We conducted an observational, retrospective, multicentre study of patients with IS due to CAD recorded in the National Stroke Registry of the Spanish Society of Neurology during the period 2011-2019. Comparative analyses were performed between: a) patients with CAD treated and not treated with reperfusion therapies and b) patients treated with reperfusion for IS due to CAD and patients treated with reperfusion for IS due to other causes. Epidemiological data, stroke variables, and outcomes at discharge and at 3 months were included in the analysis. RESULTS The study included 21,037 patients with IS: 223 (1%) had IS due to CAD, of whom 68 (30%) received reperfusion treatment. Reperfusion treatments were used less frequently in cases of vertebral artery dissection and more frequently in patients with carotid artery occlusion. Compared to patients with IS due to other causes, patients with CAD were younger, more frequently underwent mechanical thrombectomy, and less frequently received intravenous fibrinolysis. Rates of haemorrhagic complications, mortality, and independence at 3 months were similar in both groups. CONCLUSIONS Reperfusion therapy is frequently used in patients with IS due to CAD. The outcomes of these patients demonstrate the efficacy and safety of reperfusion treatments, and are comparable to the outcomes of patients with IS due to other aetiologies.
Collapse
Affiliation(s)
- D Campo-Caballero
- Servicio de Neurología, Hospital Universitario Donostia, Sant Sebastián, España.
| | - P de la Riva
- Servicio de Neurología, Hospital Universitario Donostia, Sant Sebastián, España
| | - A de Arce
- Servicio de Neurología, Hospital Universitario Donostia, Sant Sebastián, España
| | - M Martínez-Zabaleta
- Servicio de Neurología, Hospital Universitario Donostia, Sant Sebastián, España
| | | | - J Ekiza
- Servicio de Neurología, Hospital Universitario Donostia, Sant Sebastián, España
| | - P Iruzubieta
- Servicio de Neurología, Hospital Universitario Donostia, Sant Sebastián, España
| | - F Purroy
- Servicio de Neurología, Hospital Arnau de Vilanova de Lleida, Lleida, España
| | - B Fuentes
- Servicio de Neurología, Hospital Universitario La Paz, Madrid, España
| | - M de Lera Alfonso
- Servicio de Neurología, Hospital Clínico Universitario de Valladolid, Valladolid, España
| | - J Krupinski
- Servicio de Neurología, Hospital Universitari Mútua de Terrassa, Terrassa, España
| | | | - E Palomeras
- Servicio de Neurología, Hospital de Mataró, Mataró, España
| | - D Guisado-Alonso
- Servicio de Neurología, Hospital de la Santa Creu i Sant Pau, Barcelona, España
| | - M Rodríguez-Yáñez
- Servicio de Neurología, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, España
| | - X Ustrell
- Servicio de Neurología, Hospital Universitari Joan XXIII, Tarragona, España
| | | | | | - M Paré-Curell
- Servicio de Neurología, Hospital Universitari Germans Trias i Pujol, Badalona, España
| | - J Tembl
- Servicio de Neurología, Hospital Universitari i Politécnic La Fe, Valencia, España
| | - S Cajaraville
- Servicio de Neurología, Complejo Hospitalario Universitario de A Coruña, A Coruña, España
| | - M Garcés
- Servicio de Neurología, Hospital Clínico Lozano Blesa, Zaragoza, España
| | - J Serena
- Servicio de Neurología, Hospital Universitari Dr. Josep Trueta, Girona, España
| |
Collapse
|
6
|
|
7
|
Rodriguez-Antiguedad Munoz J, Munoz-Lopetegi A, Andres-Marin N, Fernandez-Garcia de Eulate G, de Arce-Borda A, de la Riva P. [Acute symmetrical lesions in the basal ganglia within the context of uremia]. Rev Neurol 2017; 65:234-235. [PMID: 28849866] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Affiliation(s)
| | | | | | | | | | - P de la Riva
- Hospital Universitario Donostia, San Sebastian, Espana
| |
Collapse
|
8
|
Tainta M, de la Riva P, Gonzalez F, Marti-Masso JF, Goenaga MA. [Rhomboencephalitis and endocarditis caused by Listeria monocytogenes: an unreported association]. Rev Neurol 2016; 63:46-48. [PMID: 27345281] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Affiliation(s)
- M Tainta
- Hospital Donostia, 20014 San Sebastian, Espana
| | | | - F Gonzalez
- Hospital Donostia, 20014 San Sebastian, Espana
| | - J F Marti-Masso
- Hospital Donostia, 20014 San Sebastian, Espana
- Universidad del Pais Vasco, Donostia-San Sebastian, Espana
- Instituto Biodonostia, San Sebastian, Espana
| | - M A Goenaga
- Hospital Donostia, 20014 San Sebastian, Espana
| |
Collapse
|
9
|
Moreno-Ramírez D, Ferrándiz L, Ojeda-Vila T, Mendonça F, de la Riva P. Axillary Sentinel Lymph Node Biopsy: Video of the Surgical Procedure. Actas Dermo-Sifiliográficas (English Edition) 2016. [DOI: 10.1016/j.adengl.2016.03.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
10
|
Moreno-Ramírez D, Ferrándiz L, Ojeda-Vila T, Mendonça FMI, de la Riva P. Axillary Sentinel Lymph Node Biopsy: Video of the Surgical Procedure. Actas Dermosifiliogr 2016; 107:425-6. [PMID: 26970655 DOI: 10.1016/j.ad.2016.02.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2015] [Revised: 01/26/2016] [Accepted: 02/03/2016] [Indexed: 11/26/2022] Open
Affiliation(s)
- D Moreno-Ramírez
- Unidad de Gestión Clínica de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario Virgen Macarena, Sevilla, España.
| | - L Ferrándiz
- Unidad de Gestión Clínica de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario Virgen Macarena, Sevilla, España
| | - T Ojeda-Vila
- Unidad de Gestión Clínica de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario Virgen Macarena, Sevilla, España
| | - F M I Mendonça
- Unidad de Gestión Clínica de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario Virgen Macarena, Sevilla, España
| | - P de la Riva
- Unidad de Medicina Nuclear, Hospital Universitario Virgen Macarena, Sevilla, España
| |
Collapse
|
11
|
Tainta M, de la Riva P, Urtasun MÁ, Martí-Massó JF. Reversible delayed post-hypoxic leukoencephalopathy. Neurologia 2016; 33:59-61. [PMID: 26774411 DOI: 10.1016/j.nrl.2015.11.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2015] [Revised: 11/06/2015] [Accepted: 11/15/2015] [Indexed: 11/27/2022] Open
Affiliation(s)
- M Tainta
- Servicio de Neurología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España.
| | - P de la Riva
- Servicio de Neurología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España
| | - M Á Urtasun
- Servicio de Neurología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España
| | - J F Martí-Massó
- Servicio de Neurología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España; Facultad de Medicina, Universidad País Vasco, San Sebastián, Guipúzcoa, España; Área de Neurociencias, Instituto Biodonostia, San Sebastián, Guipúzcoa, España
| |
Collapse
|
12
|
de la Riva P, Martinez Zabaleta M, Arruti González M, Urtasun Ocariz M. Failure mode and effect analysis applied to the procedure for intrathecal chemotherapy. Neurología (English Edition) 2015. [DOI: 10.1016/j.nrleng.2013.03.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
13
|
de la Riva P, de Arce Borda A, Díez González N, Goenaga Sanchez M. Current neurological mortality rates in infectious endocarditis. Neurología (English Edition) 2014. [DOI: 10.1016/j.nrleng.2012.11.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
14
|
de la Riva P, Martinez Zabaleta MT, Arruti González M, Urtasun Ocariz MA. Failure mode and effect analysis applied to the procedure for intrathecal chemotherapy. Neurologia 2013; 30:62-4. [PMID: 23735625 DOI: 10.1016/j.nrl.2013.03.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2013] [Accepted: 03/16/2013] [Indexed: 10/26/2022] Open
Affiliation(s)
- P de la Riva
- Servicio de Neurología, Hospital Donostia, San Sebastián, Guipúzcoa, España.
| | | | - M Arruti González
- Servicio de Neurología, Hospital Donostia, San Sebastián, Guipúzcoa, España
| | - M A Urtasun Ocariz
- Servicio de Neurología, Hospital Donostia, San Sebastián, Guipúzcoa, España
| |
Collapse
|
15
|
de la Riva P, Maneiro M, Martí-Massó JF, López de Munain A. Hypoxic ischaemic encephalopathy: lesions on magnetic resonance. Neurologia 2011; 26:371-2. [PMID: 21345537 DOI: 10.1016/j.nrl.2010.12.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2010] [Revised: 11/03/2010] [Accepted: 12/01/2010] [Indexed: 10/18/2022] Open
|